Rsv vaccine
CR20260067APending Publication Date: 2026-05-20ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CR202600067
- Authority / Receiving Office
- CR · CR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-07-18
- Filing Date
- 2024-07-18
- Publication Date
- 2026-05-20
Abstract
A vaccine against RSV is provided herein. The vaccine comprises an mRNA encoding a stabilized RSV prefusion F protein immunogen, linked to a lumazine synthase-based scaffold.
Need to check novelty before this filing date? Find Prior Art